Tilray Brands (TSE:TLRY) Shares Up 13.3% - Still a Buy?

Key Points

• Tilray Brands, Inc. shares increased by 13.3% on Monday, reaching a maximum price of C$1.11 after closing at C$0.90.
• The company has a debt-to-equity ratio of 10.76 and a market capitalization of C$818.35 million, indicating potential financial concerns.
• Tilray mainly focuses on the Canadian cannabis market and exports medical cannabis internationally, in addition to offering CBD products and beer in the U.S.

Tilray Brands, Inc. (TSE:TLRY - Get Free Report) traded up 13.3% during mid-day trading on Monday . The company traded as high as C$1.11 and last traded at C$1.02. 3,900,548 shares changed hands during mid-day trading, an increase of 132% from the average session volume of 1,684,094 shares. The stock had previously closed at C$0.90.

Tilray Brands Trading Down 5.2%

The stock has a market capitalization of C$1.05 billion, a price-to-earnings ratio of -3.94 and a beta of 2.19. The company has a debt-to-equity ratio of 10.76, a quick ratio of 2.16 and a current ratio of 2.54. The business has a 50-day moving average of C$0.79 and a 200-day moving average of C$0.86.

Tilray Brands Company Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.